Roivant Sciences Ltd. () News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 1282204,
    "name": "Roivant Sciences Ltd.",
    "stock_name": "Roivant Sciences Ltd.",
    "full_name": "Roivant Sciences Ltd.",
    "name_url": "stocks-analysis/roivant-sciences",
    "exchange": 210,
    "exchangecode": "NAS",
    "country_id": 2,
    "currency": "USD",
    "cmp": "21.18",
    "chg": 1.08,
    "chgp": "5.37%",
    "dir": 1,
    "prev_price": "20.10",
    "mcapval": "8,816.00",
    "mcap": "Small Cap",
    "scripcode": "",
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 2305,
    "indexname": "S&P 500",
    "isin": "BMG762791017",
    "curr_date": "Dec 04",
    "curr_time": "",
    "bse_nse_vol": "13.59 M",
    "exc_status": "Active",
    "traded_date": "Dec 04, 2025",
    "traded_date_str": "2025 12 04",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/roivant-sciences-1282204-210&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Roivant Sciences Hits New 52-Week High of $20.77, Up 94.9% Year-to-Date",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/roivant-sciences-hits-new-52-week-high-of-2077-up-949-year-to-date-3686452",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/RoivantSciences_priceRelatedfactors_3686452.png",
        "date": "2025-11-10 17:14:42",
        "description": "Roivant Sciences has achieved a new 52-week high of USD 20.77, reflecting a substantial year-over-year performance increase. As a small-cap company in the Pharmaceuticals & Biotechnology sector, it has a market capitalization of USD 8,816 million and showcases notable resilience despite its loss-making status."
      },
      {
        "title": "Roivant Sciences Hits New 52-Week High at $20.68, Up 94.42% Year-to-Date",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/roivant-sciences-hits-new-52-week-high-at-2068-up-9442-year-to-date-3680170",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/RoivantSciences_priceRelatedfactors_3680170.png",
        "date": "2025-11-07 16:05:44",
        "description": "Roivant Sciences has achieved a new 52-week high, reflecting significant growth over the past year. The company, with a market capitalization of USD 8,816 million, has outperformed the S&P 500. However, it remains loss-making, with a negative return on equity and no dividend yield, emphasizing its growth-oriented strategy."
      },
      {
        "title": "Roivant Sciences Hits New 52-Week High of $20.09, Up 88.94%",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/roivant-sciences-hits-new-52-week-high-of-2009-up-8894-3667304",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/RoivantSciences_priceRelatedfactors_3667304.png",
        "date": "2025-11-03 17:10:29",
        "description": "Roivant Sciences achieved a new 52-week high of USD 20.09 on October 31, 2025, reflecting an impressive one-year performance of 88.94%. With a market capitalization of USD 8,816 million, the company faces challenges, including a negative return on equity and a competitive industry landscape."
      },
      {
        "title": "Roivant Sciences Hits New 52-Week High of $19.66, Up 85%",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/roivant-sciences-hits-new-52-week-high-of-1966-up-85-3661962",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/10/RoivantSciences_priceRelatedfactors_3661962.png",
        "date": "2025-10-31 16:17:04",
        "description": "Roivant Sciences has achieved a new 52-week high, reflecting an impressive performance over the past year, significantly outpacing broader market growth. As a small-cap player in the Pharmaceuticals & Biotechnology sector, the company faces challenges, including a negative return on equity and a loss-making status, amidst its innovative strategies."
      },
      {
        "title": "Roivant Sciences Hits New 52-Week High of $17.12, Up 60.59%",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/roivant-sciences-hits-new-52-week-high-of-1712-up-6059-3626635",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/10/RoivantSciences_priceRelatedfactors_3626635.png",
        "date": "2025-10-16 18:21:01",
        "description": "Roivant Sciences has achieved a new 52-week high of USD 17.12, reflecting a significant increase over the past year. The company, with a market capitalization of USD 8,816 million, operates in the Pharmaceuticals & Biotechnology sector and has experienced notable volatility, despite remaining in a loss-making position."
      },
      {
        "title": "Roivant Sciences Hits New 52-Week High at $16.79, Surges 53.69%",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/roivant-sciences-hits-new-52-week-high-at-1679-surges-5369-3601624",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/10/RoivantSciences_priceRelatedfactors_3601624.png",
        "date": "2025-10-07 21:51:21",
        "description": "Roivant Sciences achieved a new 52-week high of USD 16.79 on October 6, 2025, reflecting a strong one-year performance of 53.69%. With a market capitalization of USD 8,816 million, the company operates in the Pharmaceuticals & Biotechnology sector, despite being loss-making and not offering dividends."
      },
      {
        "title": "Roivant Sciences Hits New 52-Week High at $16.19, Up 52.84%",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/roivant-sciences-hits-new-52-week-high-at-1619-up-5284-3595630",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/10/RoivantSciences_priceRelatedfactors_3595630.png",
        "date": "2025-10-06 17:35:03",
        "description": "Roivant Sciences has achieved a new 52-week high of USD 16.19, reflecting a strong performance over the past year with a 52.84% increase. The company, with a market capitalization of USD 8,816 million, operates in the Pharmaceuticals & Biotechnology industry, despite facing financial challenges."
      },
      {
        "title": "Roivant Sciences Hits New 52-Week High of $16.14, Up 48.87%",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/roivant-sciences-hits-new-52-week-high-of-1614-up-4887-3588381",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/10/RoivantSciences_priceRelatedfactors_3588381.png",
        "date": "2025-10-02 22:35:37",
        "description": "Roivant Sciences has achieved a new 52-week high of USD 16.14, significantly up from its low of USD 8.73, showcasing strong performance over the past year. With a market capitalization of USD 8,816 million, the company operates in the Pharmaceuticals & Biotechnology sector despite ongoing financial challenges."
      },
      {
        "title": "Is Roivant Sciences Ltd. technically bullish or bearish?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-roivant-sciences-ltd-technically-bullish-or-bearish-3546168",
        "imagepath": "",
        "date": "2025-09-20 19:26:23",
        "description": "As of 22 August 2025, the technical trend for Roivant Sciences Ltd. has changed from mildly bullish to bullish. The weekly and monthly MACD indicators are bullish, and Bollinger Bands also indicate a bullish stance on both time frames. The daily moving averages are bullish as well. However, the KST shows a mildly bearish signal on the monthly, and both the weekly and monthly Dow Theory and OBV are mildly bullish. \n\nThe stock has demonstrated strong performance compared to the S&P 500, with a 1-month return of 27.77% versus 2.33% for the index, and a 3-year return of 364.31% compared to 70.41%. Overall, the current technical stance is bullish with strong momentum indicators supporting this view...."
      }
    ],
    "total": 16,
    "sid": "1282204",
    "stock_news_url": "https://www.marketsmojo.com/news/roivant-sciences-1282204"
  },
  "announcements": "",
  "corporate_actions": {
    "msg": "No corporate action Found"
  }
}

News and Views

Roivant Sciences Hits New 52-Week High of $20.77, Up 94.9% Year-to-Date

2025-11-10 17:14:42

Roivant Sciences has achieved a new 52-week high of USD 20.77, reflecting a substantial year-over-year performance increase. As a small-cap company in the Pharmaceuticals & Biotechnology sector, it has a market capitalization of USD 8,816 million and showcases notable resilience despite its loss-making status.

Roivant Sciences Hits New 52-Week High at $20.68, Up 94.42% Year-to-Date

2025-11-07 16:05:44

Roivant Sciences has achieved a new 52-week high, reflecting significant growth over the past year. The company, with a market capitalization of USD 8,816 million, has outperformed the S&P 500. However, it remains loss-making, with a negative return on equity and no dividend yield, emphasizing its growth-oriented strategy.

Roivant Sciences Hits New 52-Week High of $20.09, Up 88.94%

2025-11-03 17:10:29

Roivant Sciences achieved a new 52-week high of USD 20.09 on October 31, 2025, reflecting an impressive one-year performance of 88.94%. With a market capitalization of USD 8,816 million, the company faces challenges, including a negative return on equity and a competitive industry landscape.

Roivant Sciences Hits New 52-Week High of $19.66, Up 85%

2025-10-31 16:17:04

Roivant Sciences has achieved a new 52-week high, reflecting an impressive performance over the past year, significantly outpacing broader market growth. As a small-cap player in the Pharmaceuticals & Biotechnology sector, the company faces challenges, including a negative return on equity and a loss-making status, amidst its innovative strategies.

Roivant Sciences Hits New 52-Week High of $17.12, Up 60.59%

2025-10-16 18:21:01

Roivant Sciences has achieved a new 52-week high of USD 17.12, reflecting a significant increase over the past year. The company, with a market capitalization of USD 8,816 million, operates in the Pharmaceuticals & Biotechnology sector and has experienced notable volatility, despite remaining in a loss-making position.

Roivant Sciences Hits New 52-Week High at $16.79, Surges 53.69%

2025-10-07 21:51:21

Roivant Sciences achieved a new 52-week high of USD 16.79 on October 6, 2025, reflecting a strong one-year performance of 53.69%. With a market capitalization of USD 8,816 million, the company operates in the Pharmaceuticals & Biotechnology sector, despite being loss-making and not offering dividends.

Roivant Sciences Hits New 52-Week High at $16.19, Up 52.84%

2025-10-06 17:35:03

Roivant Sciences has achieved a new 52-week high of USD 16.19, reflecting a strong performance over the past year with a 52.84% increase. The company, with a market capitalization of USD 8,816 million, operates in the Pharmaceuticals & Biotechnology industry, despite facing financial challenges.

Roivant Sciences Hits New 52-Week High of $16.14, Up 48.87%

2025-10-02 22:35:37

Roivant Sciences has achieved a new 52-week high of USD 16.14, significantly up from its low of USD 8.73, showcasing strong performance over the past year. With a market capitalization of USD 8,816 million, the company operates in the Pharmaceuticals & Biotechnology sector despite ongoing financial challenges.

Is Roivant Sciences Ltd. technically bullish or bearish?

2025-09-20 19:26:23

As of 22 August 2025, the technical trend for Roivant Sciences Ltd. has changed from mildly bullish to bullish. The weekly and monthly MACD indicators are bullish, and Bollinger Bands also indicate a bullish stance on both time frames. The daily moving averages are bullish as well. However, the KST shows a mildly bearish signal on the monthly, and both the weekly and monthly Dow Theory and OBV are mildly bullish. The stock has demonstrated strong performance compared to the S&P 500, with a 1-month return of 27.77% versus 2.33% for the index, and a 3-year return of 364.31% compared to 70.41%. Overall, the current technical stance is bullish with strong momentum indicators supporting this view....

View All News